Navigation Links
China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
Date:9/21/2013

Dallas, TX (PRWEB) September 22, 2013

Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered on chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

Complete report is available at http://www.rnrmarketresearch.com/pharmapoint-non-small-cell-lung-cancer-china-drug-forecast-and-market-analysis-to-2022-market-report.html.

This report estimates that branded NSCLC market in China will grow in the forecast period. This increase will be due largely to an increasing aging population; increased use of EGFR and ALK targeted therapies and increased numbers of people covered by private health insurance.

Scope
Overview of NSCLC including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in China including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in China from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting China NSCLC market.

Reasons to Buy

  • Understand and Capitalize by Identifying Products That Are Most Likely to Ensure a Robust Return
  • Stay ahead of the competition by understanding the changing competitive landscape for NSCLC
  • Effectively Plan Your M&A and Partnership Strategies by Identifying Drugs With the Most Promising Sales Potential
  • Make More Informed Business Decisions from Insightful and In-Depth Analysis of Drug Performance
  • Obtain Sales Forecast for Drugs from 2012-2022 in China

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=114312.

Browse more reports on Respiratory Therapeutics Market http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics.

Contact sales (at) rnrmarketresearch (dot) com for further information.

About Us:

RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-non-small-cell-lung/drug-market-report/prweb11145242.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. China Human Rabies Vaccine Industry 2013 Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
2. 2013 China Medical Insurance Inflation Rates Revealed
3. China Poultry Vaccine Market Analysis
4. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at RnRMarketResearch.com
5. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
6. China Independent Clinical Laboratory Industry Report, 2013-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2015
7. Autonomous Clinical Laboratory Market in China 2013 Analysis & 2015 Forecasts in New Report Now Available at RnRMarketResearch.com
8. China BCAAs Market (Branched-Chain Amino Acids) Suppy & Forecasts in a New Research at ReportsnReports.com
9. Artisan Business Group Announces EB-5 China Trade Mission Itinerary
10. China Water and Air Pollution Impacts Food Supply Reports Water Advocate Sharon Kleyne
11. New risk model highlights arsenic risk in Chinas groundwater
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: